Donna French of KORU Medical Systems (KRMD) receives 3,472-share stock grant

Rhea-AI Filing Summary

French Donna reported acquisition or exercise transactions in this Form 4 filing.

KORU Medical Systems director Donna French received a grant of Common Stock reported in a Form 4. She was awarded 3,472 shares at a value of $4.32 per share as a compensation-related grant, not an open-market purchase. Following this award, she directly holds 94,943 shares of KORU Medical Systems common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider French Donna

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,472	$4.32	$15K

Holdings After Transaction: Common Stock — 94,943 shares (Direct)

Footnotes (1)

Key Figures

Stock grant size: 3,472 shares Grant value per share: $4.32 per share Total shares after grant: 94,943 shares

3 metrics

Stock grant size 3,472 shares Common Stock grant reported for Donna French

Grant value per share $4.32 per share Value used for the Common Stock grant

Total shares after grant 94,943 shares Donna French direct holdings following the transaction

Key Terms

Common Stock, Grant, award, or other acquisition, Form 4

3 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

French Donna

(Last) (First) (Middle)

C/O KORU MEDICAL SYSTEMS, INC.

100 CORPORATE DRIVE

(Street)

MAHWAH NEW JERSEY 07430

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A		3,472	A	$4.32	94,943	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.

	/s/ Thomas Adams - Attorney-in-Fact	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did KORU Medical Systems (KRMD) report for Donna French?

KORU Medical Systems reported that director Donna French received a grant of 3,472 shares of Common Stock. The Form 4 describes this as a grant, award, or other acquisition, reflecting compensation rather than an open-market stock purchase or sale.

How many KORU Medical Systems (KRMD) shares were granted to Donna French?

Donna French was granted 3,472 shares of KORU Medical Systems Common Stock. This award increased her direct holdings and is characterized in the filing as a grant, award, or other acquisition, rather than a market transaction initiated by her in the open market.

At what price was Donna French’s KORU Medical Systems (KRMD) stock grant valued?

The 3,472-share grant to Donna French was valued at $4.32 per share. This per-share value is used in the Form 4 entry for the compensation-related acquisition of KORU Medical Systems Common Stock, not as a recorded open-market purchase price.

How many KORU Medical Systems (KRMD) shares does Donna French hold after this transaction?

After receiving the 3,472-share grant, Donna French directly holds 94,943 shares of KORU Medical Systems Common Stock. This total reflects her direct ownership immediately following the reported award and provides context for the size of the new grant relative to her position.

Was Donna French’s KORU Medical Systems (KRMD) transaction a market buy or a compensation grant?

The transaction is reported as a compensation-related grant, award, or other acquisition, not an open-market buy. The Form 4 uses code “A” and describes it as a grant/award acquisition, indicating the shares were awarded rather than purchased on a stock exchange.